Crotonyl-HIST1H4A (K12) Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to Crotonyl-HIST1H4A (K12) Antibody

Crotonyl-HIST1H4A (K12) Antibody is a polyclonal antibody specifically designed to detect histone H4 crotonylation at lysine 12 (H4K12cr), a post-translational modification (PTM) associated with transcriptional regulation and chromatin dynamics . This antibody is generated using a synthetic peptide immunogen derived from the crotonyl-lysine 12 region of human histone H4, ensuring high specificity for this modification .

Biological Relevance of H4K12 Crotonylation

Crotonylation is a conserved histone modification that neutralizes lysine’s positive charge, destabilizing nucleosome-DNA interactions and promoting transcriptional activation . Key findings include:

  • Functional Parallels to Acetylation: Like acetylation, crotonylation is enriched at transcription start sites (TSS) and enhancers, but it exhibits distinct regulatory roles due to its four-carbon planar structure .

  • Enzymatic Regulation: The Piccolo NuA4 complex (containing Esa1) catalyzes H4K12cr in vitro, linking this modification to chromatin remodeling and gene expression .

  • Role in Disease: Dysregulated crotonylation is implicated in cancer, inflammation, and stem cell differentiation, with H4K12cr serving as a biomarker for active chromatin states .

Validation and Selectivity

  • Specificity: The antibody does not cross-react with acetylated, butyrylated, or propionylated histone H4 at K12, as confirmed by peptide competition assays .

  • Structural Insights: The crotonyl group’s planar structure is recognized via hydrophobic interactions in the antibody’s binding pocket, ensuring selective detection .

  • Functional Assays: Used in chromatin immunoprecipitation (ChIP) to map H4K12cr distribution, revealing enrichment at promoters of genes involved in metabolism and inflammation .

Research Applications

  • Chromatin Dynamics: Identifies H4K12cr in studies exploring nucleosome destabilization during spermatogenesis or DNA repair .

  • Gene Expression Profiling: Detects crotonylation-mediated transcriptional activation in macrophages exposed to lipopolysaccharides (LPS) .

  • Comparative Epigenetics: Distinguishes crotonylation from acetylation in histone turnover assays, aiding mechanistic studies of PTM crosstalk .

Limitations and Considerations

  • Species Restriction: Primarily validated for human samples; cross-reactivity with mouse or rat tissues requires additional verification .

  • Buffer Compatibility: Contains glycerol and sodium azide, which may interfere with certain downstream assays .

  • Custom Production: Lead times of 3–4 weeks are typical, and orders are non-refundable once in production .

Future Directions

Recent studies highlight the potential of H4K12cr as a therapeutic target in diseases driven by epigenetic dysregulation, such as leukemia and neurodegenerative disorders . Advances in super-resolution microscopy and single-cell sequencing are expected to enhance spatial mapping of this modification in heterogeneous cell populations.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship products within 1-3 business days of receiving your order. Delivery times may vary depending on the shipping method or location. Please consult your local distributor for specific delivery time estimates.
Synonyms
dJ160A22.1 antibody; dJ160A22.2 antibody; dJ221C16.1 antibody; dJ221C16.9 antibody; FO108 antibody; H4 antibody; H4.k antibody; H4/a antibody; H4/b antibody; H4/c antibody; H4/d antibody; H4/e antibody; H4/g antibody; H4/h antibody; H4/I antibody; H4/j antibody; H4/k antibody; H4/m antibody; H4/n antibody; H4/p antibody; H4_HUMAN antibody; H4F2 antibody; H4F2iii antibody; H4F2iv antibody; H4FA antibody; H4FB antibody; H4FC antibody; H4FD antibody; H4FE antibody; H4FG antibody; H4FH antibody; H4FI antibody; H4FJ antibody; H4FK antibody; H4FM antibody; H4FN antibody; H4M antibody; HIST1H4A antibody; HIST1H4B antibody; HIST1H4C antibody; HIST1H4D antibody; HIST1H4E antibody; HIST1H4F antibody; HIST1H4H antibody; HIST1H4I antibody; HIST1H4J antibody; HIST1H4K antibody; HIST1H4L antibody; HIST2H4 antibody; HIST2H4A antibody; Hist4h4 antibody; Histone 1 H4a antibody; Histone 1 H4b antibody; Histone 1 H4c antibody; Histone 1 H4d antibody; Histone 1 H4e antibody; Histone 1 H4f antibody; Histone 1 H4h antibody; Histone 1 H4i antibody; Histone 1 H4j antibody; Histone 1 H4k antibody; Histone 1 H4l antibody; Histone 2 H4a antibody; histone 4 H4 antibody; Histone H4 antibody; MGC24116 antibody
Target Names
HIST1H4A
Uniprot No.

Target Background

Function
Histone H4 is a core component of nucleosomes, which are the fundamental units of chromatin. Nucleosomes wrap and compact DNA, limiting DNA accessibility to cellular machinery that require DNA as a template. Therefore, histones play a pivotal role in regulating transcription, DNA repair, DNA replication, and chromosomal stability. DNA accessibility is modulated through a complex interplay of post-translational modifications of histones, also known as the histone code, and nucleosome remodeling.
Gene References Into Functions
  1. Studies demonstrate that PP32 and SET/TAF-Ibeta proteins inhibit HAT1-mediated H4 acetylation. PMID: 28977641
  2. Research suggests that post-translational modifications of histones, specifically trimethylation of lysine 36 in H3 (H3K36me3) and acetylation of lysine 16 in H4 (H4K16ac), are involved in DNA damage repair. H3K36me3 stimulates H4K16ac upon DNA double-strand break, and this process requires the involvement of SETD2, LEDGF, and KAT5 (SETD2 = SET domain containing 2; LEDGF = lens epithelium-derived growth factor; KAT5 = lysine acetyltransferase 5). PMID: 28546430
  3. Data indicates that Omomyc protein co-localizes with proto-oncogene protein c-myc (c-Myc), protein arginine methyltransferase 5 (PRMT5), and histone H4 H4R3me2s-enriched chromatin domains. PMID: 26563484
  4. H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription. PMID: 25788266
  5. Systemic lupus erythematosus appears to be associated with an imbalance in histone acetyltransferases and histone deacetylase enzymes, favoring pathological H4 acetylation. PMID: 25611806
  6. Sumoylated human histone H4 inhibits chromatin compaction by preventing long-range internucleosomal interactions. PMID: 25294883
  7. Acetylation at lysine 5 of histone H4 is associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus. PMID: 25283865
  8. Increased histone H4 acetylation caused by hypoxia in human neuroblastoma cell lines correlates with increased levels of N-myc transcription factor in these cells. PMID: 24481548
  9. Research indicates that histone assembly during the G1-phase is restricted to CENP-A and H4. PMID: 23363600
  10. This study investigated the distribution of H4K12ac, a specific histone modification, in human sperm and characterized its specific enrichment sites in promoters throughout the entire human genome. PMID: 22894908
  11. SRP68/72 heterodimers are major nuclear proteins whose binding to the histone H4 tail is inhibited by H4R3 methylation. PMID: 23048028
  12. TNF-alpha inhibition of AQP5 expression in human salivary gland acinar cells is attributed to an epigenetic mechanism involving the suppression of histone H4 acetylation. PMID: 21973049
  13. Data suggests that global histone H3 and H4 modification patterns may serve as potential markers for tumor recurrence and disease-free survival in non-small cell lung cancer. PMID: 22360506
  14. HAT1 differentially affects nucleosome assembly of H3.1-H4 and H3.3-H4. PMID: 22228774
  15. Phosphorylation of histone H4 Ser 47, catalyzed by the PAK2 kinase, promotes nucleosome assembly of H3.3-H4 and inhibits nucleosome assembly of H3.1-H4 by enhancing the binding affinity of HIRA to H3.3-H4 and reducing the association of CAF-1 with H3.1-H4. PMID: 21724829
  16. Imatinib-induced hemoglobinization and erythroid differentiation in K562 cells are associated with global histone H4 modifications. PMID: 20949922
  17. Research reveals the molecular mechanisms by which DNA sequences within specific gene bodies are sufficient to nucleate the monomethylation of histone H4 lysine 200, which in turn reduces gene expression by half. PMID: 20512922
  18. Histone H4 expression is downregulated by zinc and upregulated by docosahexaenoate in a neuroblastoma cell line. PMID: 19747413
  19. Low levels of histone acetylation are associated with the development and progression of gastric carcinomas, possibly through alteration of gene expression. PMID: 12385581
  20. Overexpression of MTA1 protein and acetylation levels of histone H4 protein are closely related. PMID: 15095300
  21. Peptidylarginine deiminase 4 (PAD4) regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine. Data suggests that PAD4 mediates gene expression by regulating Arg methylation and citrullination in histones. PMID: 15345777
  22. The lack of biotinylation of K12 in histone H4 is an early signaling event in response to double-strand breaks. PMID: 16177192
  23. Incorporation of acetylated histone H4-K16 into nucleosomal arrays inhibits the formation of compact 30-nanometer-like fibers and hinders the ability of chromatin to form cross-fiber interactions. PMID: 16469925
  24. Apoptosis is associated with global DNA hypomethylation and histone deacetylation events in leukemia cells. PMID: 16531610
  25. BTG2 contributes to retinoic acid activity by promoting differentiation through a gene-specific modification of histone H4 arginine methylation and acetylation levels. PMID: 16782888
  26. There is a relationship between histone H4 modification, epigenetic regulation of BDNF gene expression, and long-term memory for extinction of conditioned fear. PMID: 17522015
  27. The H4 tail and its acetylation play novel roles in mediating the recruitment of multiple regulatory factors that can alter chromatin states for transcription regulation. PMID: 17548343
  28. Brd2 bromodomain 2 exists as a monomer in solution and dynamically interacts with H4-AcK12. Additional secondary elements in the long ZA loop may be a common feature of BET bromodomains. PMID: 17848202
  29. Spermatids Hypac-H4 impairment in mixed atrophy was not further deteriorated by AZFc region deletion. PMID: 18001726
  30. The interaction between SET8 and PCNA couples H4-K20 methylation with DNA replication. PMID: 18319261
  31. H4K20 monomethylation and PR-SET7 are essential for L3MBTL1 function. PMID: 18408754
  32. High expression of acetylated H4 is more prevalent in aggressive than indolent cutaneous T-cell lymphoma. PMID: 18671804
  33. Findings indicate a significant role of histone H4 modifications in bronchial carcinogenesis. PMID: 18974389
  34. Results suggest that acetylation of histone H4 K16 during the S-phase leads to early replicating chromatin domains acquiring the H4K16ac-K20me2 epigenetic label, which persists on the chromatin throughout mitosis and is deacetylated in early G1-phase of the subsequent cell cycle. PMID: 19348949
  35. Acetylated H4 is overexpressed in diffuse large B-cell lymphoma and peripheral T-cell lymphoma compared to normal lymphoid tissue. PMID: 19438744
  36. The release of histone H4 via holocrine secretion from the sebaceous gland may play a crucial role in innate immunity. PMID: 19536143
  37. Histone modification, including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4, may be involved in CD11b transcription during HL-60 leukemia cell reprogramming to terminal differentiation. PMID: 19578722
  38. A role for Cdk7 in regulating elongation is further supported by enhanced histone H4 acetylation and diminished histone H4 trimethylation on lysine 36, two marks of elongation, within genes when the kinase is inhibited. PMID: 19667075
  39. Data reveals dynamic fluctuations in histone H4 acetylation levels during mitosis, as well as acetylation changes in response to structurally distinct histone deacetylase inhibitors. PMID: 19805290
  40. Data directly implicates BBAP in the monoubiquitylation and additional posttranslational modification of histone H4 and an associated DNA damage response. PMID: 19818714

Show More

Hide All

Database Links

HGNC: 4781

OMIM: 142750

KEGG: hsa:121504

STRING: 9606.ENSP00000367034

UniGene: Hs.143080

Involvement In Disease
Chromosomal aberrations involving HISTONE H4 is a cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;6)(q27;p21), with BCL6.
Protein Families
Histone H4 family
Subcellular Location
Nucleus. Chromosome.

Q&A

Advanced Research Questions

  • What controls should be implemented when validating Crotonyl-HIST1H4A (K12) antibody specificity?

    Thorough validation of antibody specificity is essential for reliable experimental results. For Crotonyl-HIST1H4A (K12) antibodies, implement the following controls:

    Positive Controls:

    • Use cell lines or tissues known to express high levels of crotonylated H4K12 (e.g., testis tissue for many histone crotonylation marks)

    • Include crotonylation-inducing treatments (e.g., exposure to crotonate or inhibition of class I HDACs)

    Negative Controls:

    • Utilize cells where the crotonylation writer enzyme has been knocked down

    • Include crotonyl-specific eraser enzyme overexpression (e.g., HDAC overexpression)

    • Apply competing peptide blocks with crotonylated H4K12 peptides

    Specificity Tests:

    • Perform dot blot analysis with modified peptides (crotonylated H4K12 vs. other modifications like acetylated H4K12)

    • Conduct western blot analysis following CRISPR/Cas9-mediated K12R mutation in H4

    • Use mass spectrometry validation to confirm antibody pull-down specificity

    A comprehensive validation strategy increases confidence in experimental findings and helps distinguish true signals from potential cross-reactivity with similar modifications .

  • How can researchers differentiate between crotonylation and acetylation at H4K12 in experimental designs?

    Distinguishing between these similar modifications requires strategic experimental design:

    1. Sequential Immunoprecipitation: First immunoprecipitate with one antibody (e.g., acetyl-H4K12), then perform a second immunoprecipitation on the unbound fraction with the other antibody (crotonyl-H4K12)

    2. Mass Spectrometry Analysis: Use targeted MS approaches to distinguish between the mass differences of acetyl (+42 Da) and crotonyl (+68 Da) modifications

    3. Enzyme Sensitivity Tests: Treat samples with recombinant deacetylases or decrotonylases with known specificities, then observe differential removal patterns

    4. Modification-Specific Reader Proteins: Employ known reader proteins that specifically bind to either crotonylated or acetylated lysines as detection tools

    5. Metabolic Labeling: Use isotopically labeled precursors for acetyl-CoA versus crotonyl-CoA to track modification incorporation

    By combining these approaches, researchers can confidently discriminate between these closely related but functionally distinct histone modifications, enabling more accurate interpretation of their biological significance .

  • What are the known cross-reactivity challenges with Crotonyl-HIST1H4A (K12) antibodies and how can they be addressed?

    Crotonyl-HIST1H4A (K12) antibodies may exhibit cross-reactivity with:

    • Similar Modifications: Acetylation, butyrylation, or other acylations at the same position

    • Similar Epitopes: Crotonylation at other histone lysine positions with similar surrounding sequences

    • Non-Histone Proteins: Crotonylated lysines in non-histone proteins with sequence similarities

    Strategies to Address Cross-Reactivity:

    1. Pre-absorption: Incubate antibodies with competing peptides containing similar modifications to block cross-reactive antibodies

    2. Sequential Dilution Testing: Perform titration experiments to identify dilution points where specific binding is maintained but cross-reactivity is minimized

    3. Knockout Validation: Use cells/tissues where the specific histone variant is knocked out as negative controls

    4. Modification-Specific Enzymes: Employ enzymes that selectively remove only crotonylation to confirm that signal loss correlates with modification removal

    5. Peptide Array Screening: Test antibody specificity against arrays containing various histone modifications to quantify cross-reactivity

    Careful validation using these approaches can significantly improve experimental reliability and interpretation of results involving histone crotonylation at H4K12 .

  • How do dynamics of H4K12 crotonylation differ across cell cycle stages and how can this be studied?

    H4K12 crotonylation exhibits distinct patterns across the cell cycle, reflecting its functional role in chromatin regulation during different cellular processes:

    Cell Cycle PhaseH4K12 Crotonylation PatternExperimental Approach
    G1Moderate levels, associated with early-response genesSerum starvation followed by release
    SIncreased levels at replication forksThymidine block and release, EdU labeling
    G2Redistribution to specific genomic regionsRO-3306 (CDK1 inhibitor) treatment
    MGenerally decreased, with enrichment at centromeresNocodazole or colcemid treatment

    Research Methods:

    1. Cell Synchronization: Use chemical synchronization methods followed by ChIP-seq or immunofluorescence with Crotonyl-HIST1H4A (K12) antibodies

    2. FACS-ChIP: Sort cells by DNA content (cell cycle stage) before performing ChIP with the antibody

    3. Live-Cell Imaging: Use cell-permeable crotonylation probes in combination with cell cycle markers

    4. Sequential ChIP: Combine cell cycle marker proteins with H4K12cr antibodies

    5. Single-Cell Analysis: Perform single-cell sequencing approaches with crotonylation detection to observe cell-to-cell variation

    These approaches can reveal how H4K12 crotonylation contributes to cell cycle-specific gene expression programs and chromatin organization changes .

  • What are the quantitative approaches for measuring global versus locus-specific H4K12 crotonylation changes?

    Researchers can employ various techniques to quantify H4K12 crotonylation at different scales:

    Global Quantification:

    1. Mass Spectrometry: Provides precise quantification of modification stoichiometry

      • Use targeted MRM (Multiple Reaction Monitoring) for specific detection of H4K12cr

      • Apply SILAC or TMT labeling for comparative analysis across conditions

    2. ELISA-Based Assays: Allow high-throughput screening of global changes

      • Develop sandwich ELISA with Crotonyl-HIST1H4A (K12) antibodies

      • Employ automated liquid handling for large-scale screens

    3. Western Blot: Semi-quantitative approach for relative abundance measurement

      • Use fluorescent secondary antibodies for wider dynamic range

      • Apply normalization to total H4 for accurate comparison

    Locus-Specific Quantification:

    1. ChIP-qPCR: Targeted analysis of specific genomic regions

      • Design primers for regions of interest (promoters, enhancers)

      • Use spike-in controls for normalization across samples

    2. ChIP-seq: Genome-wide profiling of H4K12cr distribution

      • Apply peak calling algorithms optimized for histone modifications

      • Consider ChIP-rx for quantitative comparisons between samples

    3. CUT&RUN or CUT&Tag: Higher resolution mapping with lower background

      • Provides improved signal-to-noise ratio in low-abundance modifications

      • Requires fewer cells than traditional ChIP approaches

    Combining global and locus-specific approaches provides comprehensive insights into the functional impact of H4K12 crotonylation changes across different experimental conditions .

  • How can Crotonyl-HIST1H4A (K12) antibodies be integrated into multi-omics research approaches?

    Multi-omics integration creates more comprehensive understanding of H4K12 crotonylation function:

    1. ChIP-seq + RNA-seq Integration:

      • Correlate H4K12cr distribution with gene expression patterns

      • Identify direct transcriptional targets of H4K12cr

      • Apply mathematical models to infer causality between modification and expression

    2. ChIP-seq + ATAC-seq:

      • Associate H4K12cr with chromatin accessibility changes

      • Identify pioneer factor binding sites co-occurring with H4K12cr

      • Map the relationship between crotonylation and nucleosome positioning

    3. Proteomics + ChIP-seq:

      • Identify reader proteins that specifically bind H4K12cr using SILAC pull-downs

      • Correlate protein complex formation with genomic distribution of H4K12cr

      • Map the entire "crotonylation interactome" in specific cell types

    4. Metabolomics + ChIP-seq:

      • Investigate how metabolic pathways influence H4K12cr levels

      • Track isotopically labeled metabolites to crotonylation sites

      • Determine rate-limiting steps in crotonylation metabolism

    5. Single-cell Multi-omics:

      • Perform joint profiling of H4K12cr, chromatin accessibility, and transcription

      • Identify cell state-specific relationships between crotonylation and gene expression

      • Map modification dynamics during cellular differentiation or response

    Computational integration of these multi-omics datasets requires specialized bioinformatics pipelines, including machine learning approaches and network analysis methods, to derive meaningful biological insights from the complex interrelationships between different data types .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.